The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization

The clinical efficacy and efficiency of a 100‐IU starting dose of recombinant follicle stimulating hormone (Puregon®) in Korean women undergoing in vitro fertilization and embryo transfer

“…The findings in this study are of clinical importance in that this is the first study which employed a fixed starting dose of 100 IU of rhFSH in Asian subjects. Mean BMI was 23.2 kg/m 2 in patients of Devroey's investigation, 9 while in the present study it was 20.6 kg/m 2 . The usual regimen of ovarian hyperstimulation has been formulated upon data from Caucasians or African‐Americans.…”

“…In our study, a lower quantity of total gonadotropin was used than in Devroey et al . (1480 IU in the current study vs 1807 IU) 9 …”

Success of frozen embryo transfer: Does the type of gonadotropin influence the outcome?

“…5 In total, 247 citations were excluded, and 18 citations to comparative studies were further evaluated using the full-text manuscripts. [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49] Finally, only five studies met the inclusion criterion. 37,38,42,46,48 Before the five trials are discussed, a brief summary is presented of a number of papers which did not fulfill the inclusion criteria, but which provide interesting data on FET.…”

Mild IVF using GnRH agonist long protocol is possible: Comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose

“…Devroey et al [20] in a study with 51 patients, obtained a mean of 11.7 oocytes with a total dose of 1,807 IU of rFSH given over 13.3 days; and Moon et al [21] in a study with 40 patients, obtained 8.4 oocytes with a total dose of 1,480 IU rFSH given over 10.8 days.…”